Browse the articles below to learn more about our faculty’s latest achievements, awards and honors.
- From Science to Clinical Utility: Cxbladder Detect - Bladder Cancer Detection for Patients Who Present with Hematuria - Tamer Aboushwareb, Neal Shore & Josh Meeks11.21.2022Dr. Joshua Meeks joines a discussion with Drs. Neal Shore and Tamer Aboushwareb to provides an overview of the Cxbladder Detect urine-based cancer diagnostic test and discuss the clinical implications of the use of this test which is designed for high-risk patients who present with hematuria.
- 11.18.2022Urology Times is celebrating its 50th anniversary in 2022. To mark the occasion, they highlighted 50 of the top innovations and developments that have transformed the field of urology over the past 50 years. Ziho Lee, MD, discusses the buccal mucosa graft for urethral and ureteral stricture disease.
- 11.10.2022During the 2022 LUGPA Annual Meeting, Ashley Ross, MD, PhD, associate professor of Urology and the clinical director of the Polsky Urologic Cancer Institute at Northwestern University, discusses the emergence of PSMA-PET in prostate cancer.
- 11.10.2022In an interview during the 2022 LUGPA Annual Meeting, Ashley Ross, MD, PhD, discussed these advances as well as unmet needs in prostate cancer.
- 11.07.2022Expert panelists including Ashley Ross, MD, PhD, review risk stratification strategies for patients with prostate cancer and summarize the evolving use of conventional versus newer imaging modalities for diagnosis, treatment selection, and monitoring of these patients.
In an interview with The ASCO Post, Channa A. Amarasekera, MD decribes how the first urology clinic to specialize in care for gay and bisexual men in the United States is changing the approach to oncology care for gay and bisexual patient.
Dr. Channa Amarasekera discusses how the innovative Gay and Bisexual Men’s Urology Program has personalized treatment for LGBT+ Community.
In this video, Neil Mistry, MD, MPH, and Adam B. Murphy, MD, MBA, MSCI, discuss future research and the take-home message from the abstract, “West-African ancestry can aid prediction of high-grade prostate cancer in Black-tailored risk calculator,” which was presented at the North Central Section of the AUA Annual Meeting in Chicago, Illinois.
- 07.28.2022Two years after his treatment with Dr. Schaeffer, Dr. DeGould is healthy, grateful, and eager to give back to help future patients with cancer.
- 07.19.2022American men are sicker and die earlier than men living in other developed nations, according to a new report from the Commonwealth Fund, a non-profit organization focusing on public health issues. Dr. Nelson Bennett, MD, looks at the statistics.
William J. Catalona, MD, explains how the approach of active surveillance in prostate cancer emerged alongside the advent of PSA screening.
- 07.11.2022Alicia Morgans and Ashley Ross discuss Decipher testing, both Decipher Biopsy and Decipher for prostatectomy specimens, and how to integrate these tests into standard clinical practice.
- 07.08.2022In this video, Edward M. Schaeffer, MD, PHD, discusses the National Comprehensive Cancer Network’s process for updating its guidelines for prostate cancer.
Joshua J. Meeks, MD, PhD, recaps several presentations on bladder cancer from the 2022 American Urological Association Annual Meeting in New Orleans, Louisiana.
- 06.25.2022William Catalona, MD, explained the evolution of his views regarding active surveillance in men with low-risk prostate cancer.
Ashley E. Ross, MD, PhD, recaps several presentations on prostate cancer from the 2022 American Urological Association Annual Meeting in New Orleans, Louisiana.
Robert E. Brannigan, MD, vice-chair of Clinical Urology, discusses which men with infertility issues should receive genetic testing.
- 06.14.2022A new androgen biosynthesis inhibitor drug improved progression-free survival in prostate cancer but did not improve overall survival compared to current therapies, according to a study co-authored by Maha Hussain, MD.
- 06.01.2022In an interview with Targeted Oncology, William J. Catalona, MD, reviewed the history of active surveillance in the prostate cancer space and how the practice has become more widespread in the United States.
Joshua Halpern, MD, discusses the goals and outcomes of the study, “Elevated follicle stimulating hormone (FSH) predicts decline in semen parameters among men with normal index semen analysis,” which was presented at the 2022 American Urological Association Annual Meeting in New Orleans, Louisiana.
William Catalona, MD, a panel member at the 2022 annual American Urological Association (AUA) meeting, evaluates data indicating that the number of men with prostate cancer who opted for active surveillance (AS) doubled nationally between 2014 and 2021.
- 05.14.2022Adam B. Murphy, MD, MBA, MSCI, discusses the background and rationale for the study, “Vitamin D has a stronger impact on prostate tumor gene expression in Black men,” which he presented at the 2022 American Urological Association annual meeting in New Orleans.
Investigators at Lurie Cancer Center have identified a gene that drives enzalutamide resistance in advanced prostate cancer, according to research study led by Sarki Abdulkadir, MD.
- 05.10.2022A transcription factor generally associated with androgen receptor activity in prostate cancer has a newly discovered role in controlling lipid biosynthesis, according to a Northwestern Medicine study co-author William Catalona, MD, professor of Urology.
Patients receiving radiotherapy to treat high-risk prostate cancer also benefit from androgen deprivation therapy. The ideal duration of treatment may be roughly two years if receiving external beam radiation and one year if receiving external beam radiation with a brachytherapy boost, according to a study co-authored by Ashley Ross, MD, PhD.
- 05.03.2022This year's grant recipient includes Stephanie J. Kielb, MD, for her work with the International Organization for Women & Development (IOWD).
- 05.01.2022Channa Amarasekera, MD, discusses how the Northwestern Medicine Gay and Bisexual Men's Urology Program is helping heal a community that typically gets overlooked during their urological care.
- 04.22.2022Channa Amarasekera, MD, discusses the impact of the Gay and Bisexual Men’s Urology Program.
- 04.20.2022William J. Catalona, MD, explains why he believes the cancer label is necessary.